Results 61 to 70 of about 1,354 (149)

Complex treatment approach to primary open-angle glaucoma: focus on neuroprotection [PDF]

Клиническая офтальмология, 2019
M. Kh. Khubetsova1, V.V. Kadyshev2, B.F. Ambalova3 1S.N. Fedorov NMRC “MNTK “Eye Microsurgery”, Moscow, Russian Federation 2Moscow Genetic Research Center, Moscow, Russian Federation 3Right-Shore Central Regional Clinical Hospital ...
M. Kh. Khubetsova, V.V. Kadyshev, B.F. Ambalova   +2 more
doaj  

Optic nerve head perfusion following treatment with latanoprost 0.005% versus brimonidine tartrate 0.2% in primary open angle glaucoma: an optical coherence tomography angiography study

Journal of the Egyptian Ophthalmological Society
Purpose To assess the effects of topical latanoprost 0.005% versus brimonidine tartrate 0.2% on perfusion of optic nerve head in patients with POAG using optical coherence tomography angiography.
Yasmine A. Deiaeldin, Mohammed A. Al-Naimy, Hani A. Albialy   +2 more
doaj   +1 more source

Clinical efficacy of combination treatment for advanced-stage axial diabetic optic neuropathy

Journal of Ophthalmology, 2018
Background: There is no standard of therapy for diabetic optic neuropathy (DON) which takes into consideration the type and stage of the disease. Purpose: To assess the clinical efficacy of combined adjunct treatment with thioctic acid, a combination
M.A. Karliychuk
doaj   +1 more source

Clinical efficacy and neuroprotective effects of brimonidine in the management of glaucoma and ocular hypertension

Clinical Ophthalmology, 2008
Anna Galanopoulos1, Ivan Goldberg21Senior Visiting Ophthalmologist, South Australian Institute of Ophthalmology and Dept of Ophthalmology and Visual Sciences, University of Adelaide, South Australia; 2Clinical Associate Professor, University of Sydney ...
Anna Galanopoulos, Ivan Goldberg
doaj  

Spotlight on brimonidine topical gel 0.33% for facial erythema of rosacea: safety, efficacy, and patient acceptability

Patient Preference and Adherence, 2017
Michael S Anderson,1 Anish Nadkarni,1 Leah A Cardwell,1 Hossein Alinia,1 Steven R Feldman1–3 1Department of Dermatology, Center for Dermatology Research, 2Department of Pathology, 3Department of Public Health Sciences, Wake Forest School of ...
Anderson MS, Nadkarni A, Cardwell LA, Alinia H, Feldman SR   +4 more
doaj  

Fixed combination of topical brimonidine 0.2% and timolol 0.5% for glaucoma and uncontrolled intraocular pressure

Clinical Ophthalmology, 2008
Anne J Lee1, Peter McCluskey1,21Department of Ophthalmology, Liverpool Hospital, Liverpool, NSW, Australia; 2Faculty of Medicine, University of New South Wales, Randwick, NSW, AustraliaAbstract: Lowering IOP is the most readily modifiable risk factor to ...
Anne J Lee, Peter McCluskey
doaj  

Effect of brimonidine on anterior-chamber angle in patients with narrow angles

Philippine Journal of Ophthalmology, 2011
Objective: This study investigated the effect of brimonidine on the anterior-chamber angle in eyes with narrow angles using noncontact three-dimensional anterior-segment analyzer Pentacam.
Johanna Timoteo-Cervantes, MD, Joseph Anthony Tumbocon, MD, Ma. Margarita Lat-Luna, MD   +2 more
doaj  

Novel long-acting brimonidine tartrate loaded-PCL/PVP nanofibers for versatile biomedical applications: fabrication, characterization and antimicrobial evaluation. [PDF]

RSC Adv, 2023
Salim SA, Badawi NM, El-Moslamy SH, Kamoun EA, Daihom BA.   +4 more
europepmc   +1 more source

Effect of over-the-counter brimonidine tartrate 0.025% ophthalmic solution on pupil size in healthy adults. [PDF]

Graefes Arch Clin Exp Ophthalmol, 2021
Nejad M, Lin SR, Hwang LH, Landig M, Al-Hashimi S, Bartlett JD.   +5 more
europepmc   +1 more source

The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum]

Clinical Ophthalmology, 2015
The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum] Tsumura T, Yoshikawa K, Kimura T, et al. Clin Ophthalmol. 2014;8:1681–1687. 
Tsumura T, Yoshikawa K, Kimura T, Suzumura H, Kawashima M, Nanno M, Ishijima K, Takeda R   +7 more
doaj